PUBLICATIONS · 36250420
Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2022 Dec 1
- First author
- Bisogno G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bisogno G
- type
- Author
- name
- Fuchs J
- type
- Author
- name
- Dasgupta R
- type
- Author
- name
- Ferrari A
- type
- Author
- name
- Haduong JH
- type
- Author
- name
- Rogers T
- type
- Author
- name
- Walterhouse DO
- type
- Author
- name
- Coppadoro B
- type
- Author
- name
- Xue W
- type
- Author
- name
- Vokuhl C
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Seitz G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bisogno G
- type
- Author
- name
- Fuchs J
- type
- Author
- name
- Dasgupta R
- type
- Author
- name
- Ferrari A
- type
- Author
- name
- Haduong JH
- type
- Author
- name
- Rogers T
- type
- Author
- name
- Walterhouse DO
- type
- Author
- name
- Coppadoro B
- type
- Author
- name
- Xue W
- type
- Author
- name
- Vokuhl C
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Seitz G
- type
- Author
- bibliography ids
- nci-bib-26ecd7929d5f732f32ceaeda
- book metadata
- content sha256
- ee624deded475c44c957de1369f3041a8b8cd7e3a45b806c1493e8cc43846fef
- document type
- citation
- dois
- 10.1002/cncr.34497
- electronic publication date
- display
- 2022 Oct 17
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36250420
- immutable id
- pubmed:36250420@ee624deded475c44c957de1369f3041a8b8cd7e3a45b806c1493e8cc43846fef
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 23
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 4150-4156
- volume
- 128
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36250420
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 67768587528f159ecfe19b1794e2cd3bfba03eca1d505d26dccc589295bf58c5
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2022 Dec 1
- precision
- day
- year
- 2022
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
Preserved source evidence · Not medical advice
Triangle